| Unternehmen | 64x Bio |
|---|---|
| Branche | 🧫 Pharma & Biotech |
| Finanzierungsrunde | Series A, Early Stage |
| Eingesammelt (Mio. USD) | $55.0 |
| Größenordnung | $50-250 Mio |
| Jahr | 2022 |
| Land | USA 🇺🇸 |
| Phase | Series A, Early Stage |
| Investoren | Lifeforce Capital |
64x Bio: Pharma & Biotech aus den USA. 2022 sammelte das Team 55 Mio. $ in der Series A-Runde. Mit an Bord: Lifeforce Capital. Pitchdeck hier ansehen.
Embark on your fundraising journey with confidence – our expertly crafted resources and templates are ready to kickstart your fundraising success.
Explore decks from your industry and gain valuable insights with our curated collection of other industry-specific pitch decks.
